Treatment of Ischemic Colonic Anastomoses With Systemic Transplanted Bone Marrow Derived Mesenchymal Stem Cells

dc.contributor.author Adas, G.
dc.contributor.author Kemik, O.
dc.contributor.author Eryasar, B.
dc.contributor.author Okcu, A.
dc.contributor.author Adas, M.
dc.contributor.author Arikan, S.
dc.contributor.author Karaoz, E.
dc.date.accessioned 2025-05-10T16:57:25Z
dc.date.available 2025-05-10T16:57:25Z
dc.date.issued 2013
dc.description Adas, Mine/0000-0003-3008-6581; Erman, Gulay/0000-0002-9926-369X; Karaoz, Erdal/0000-0002-9992-833X; Kemik, Ozgur/0000-0002-4612-1428; Harman Kamali, Gulcin/0000-0003-4135-0165 en_US
dc.description.abstract BACKGROUND: The aim of the study is to investigate the healing effect of the bone-marrow derived mesenchymal stem cells (BM-MSCs) on ischemic colon anastomosis in systemic application and to recovery the adverse effect of ischemia. MATERIALS AND METHODS: Fourty male Wistar Albino rats weigthing 250-300 g were divided into four equal groups (n=10 Group 1: control; ischemic left colonic anastomoses (4th day); Group 2: control; ischemic left colonic anastomoses (7th day); Group 3: ischemic left colonic anastomoses + systemic transplanted BM-MSCs (4th day); Group 4: ischemic left colonic anastomoses + systemic transplanted BM-MSCs (7th day). BMSCs labelled with bromodeoxyuridine (BrdU) were transplanted into the vena cava. Group 1 and group 3 were killed four days after surgery. In group 2 and group 4 were sacrificed seven days after the surgical procedure. Histopathological features, hydroxyproline levels in the tissue, and anastomotic strength were investigated. RESULTS: There was no mortality all of the groups. The mean bursting pressures of ischemic colonic anastomoses in group 3 were higher than in control group 1 (4th day). We found significantly higher hydroxyproline values in group 3 and were significantly higher in group 4 than in control groups. We investigated the early period of wound healing (4th day and 7th day). When comparing between group 1 and group 3, we found higher levels for all of the histological parameters except inflammation in group 3. On day 7, when comparing between group 2 and group 4, we found higher levels for parameters of necrosis, collagen deposition. CONCLUSIONS: BM-MSCs therapy significantly accelerated all of the healing parameters for ischemic colonic anastomosis except for inflammation on fourth day. On the seventh day, BM-MSCs augmented the levels of the hydroxyproline. Histological parameters, necrosis and collagen deposition were also found to be important for healing of ischemic colonic anastomoses. However, they did not accelerate the others histological parameters especially angiogenesis. en_US
dc.identifier.issn 1128-3602
dc.identifier.scopus 2-s2.0-84884267468
dc.identifier.uri https://hdl.handle.net/20.500.14720/4039
dc.language.iso en en_US
dc.publisher verduci Publisher en_US
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.subject Stem Cells en_US
dc.subject Wound Healing en_US
dc.subject Ischemic Colon Anastomosis en_US
dc.title Treatment of Ischemic Colonic Anastomoses With Systemic Transplanted Bone Marrow Derived Mesenchymal Stem Cells en_US
dc.type Article en_US
dspace.entity.type Publication
gdc.author.id Adas, Mine/0000-0003-3008-6581
gdc.author.id Erman, Gulay/0000-0002-9926-369X
gdc.author.id Karaoz, Erdal/0000-0002-9992-833X
gdc.author.id Kemik, Ozgur/0000-0002-4612-1428
gdc.author.id Harman Kamali, Gulcin/0000-0003-4135-0165
gdc.author.scopusid 6506934951
gdc.author.scopusid 6504566099
gdc.author.scopusid 36456693500
gdc.author.scopusid 36197109000
gdc.author.scopusid 19033400300
gdc.author.scopusid 55962065600
gdc.author.scopusid 58819235200
gdc.author.wosid Adas, Mine/Gqy-5434-2022
gdc.author.wosid Kemik, Ozgur/Mgb-2153-2025
gdc.author.wosid Karaoz, Erdal/Aao-1470-2020
gdc.author.wosid Harman Kamali, Gülçin/Gqy-7483-2022
gdc.author.wosid Arıkan, Soykan/Hkf-1086-2023
gdc.author.wosid Erman, Gülay/Htn-5982-2023
gdc.author.wosid Okcu, Alparslan/F-8567-2018
gdc.coar.access metadata only access
gdc.coar.type text::journal::journal article
gdc.description.department T.C. Van Yüzüncü Yıl Üniversitesi en_US
gdc.description.departmenttemp [Adas, G.; Dogan, Y.] Bakirkoy Sadi Konuk Training & Res Hosp, Dept Gen Surg, Istanbul, Turkey; [Kemik, O.] Yuzuncu Yil Univ, Fac Med, Dept Gen Surg, Van, Turkey; [Eryasar, B.] Istanbul Univ, Inst Expt Med, Dept Immunol, Istanbul, Turkey; [Okcu, A.; Erman, G.; Karaoz, E.] Kocaeli Univ, Ctr Stem Cell & Gene Therapies Res & Practice, Inst Hlth Sci, Stem Cell Dept, Kocaeli, Turkey; [Adas, M.] Okmeydani Training & Res Hosp, Dept Endocrinol, Okmeydani, Turkey; [Arikan, S.] Istanbul Training & Res Hosp, Dept Gen Surg, Istanbul, Turkey; [Kemik, A. S.] Istanbul Univ, Fac Med, Dept Biochem, Istanbul, Turkey; [Kamali, G.] Okmeydani Training & Res Hosp, Dept Pathol, Okmeydani, Turkey en_US
gdc.description.endpage 2285 en_US
gdc.description.issue 17 en_US
gdc.description.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
gdc.description.scopusquality Q2
gdc.description.startpage 2275 en_US
gdc.description.volume 17 en_US
gdc.description.woscitationindex Science Citation Index Expanded
gdc.description.wosquality Q2
gdc.identifier.pmid 24065218
gdc.identifier.wos WOS:000325204600002
gdc.index.type WoS
gdc.index.type Scopus
gdc.index.type PubMed

Files